Evidence map›Paper›PMID 31974656›Full record

ReviewCellular and molecular life sciences : CMLS2020

The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy.

Michele Sommariva, Valentino Le Noci, Francesca Bianchi, Simone Camelliti, Andrea Balsari, Elda Tagliabue, Lucia Sfondrini

Open access · hybridAbstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 113 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed, 2 pooled it
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 2 syntheses or guidelines pooled it, 171 citations in OpenAlex.

  1. Pooled it
  2. The Human Respiratory Microbiome: Current Understandings and Future Directions.American journal of respiratory cell and molecular biology · 2023
    Pooled it
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Michele SommarivaDipartimento Di Scienze Biomediche Per La Salute, Università Degli Studi Di Milano, via Mangiagalli 31, 20133, Milano, Italy.ORCID http://orcid.org/0000-0002-7622-0996
Valentino Le NociDipartimento Di Scienze Biomediche Per La Salute, Università Degli Studi Di Milano, via Mangiagalli 31, 20133, Milano, Italy.ORCID http://orcid.org/0000-0002-7470-6909
Francesca BianchiMolecular Targeting Unit, Department of Research, Fondazione IRCCS, Istituto Nazionale Dei Tumori, via Amadeo 42, 20133, Milano, Italy.ORCID http://orcid.org/0000-0001-5197-5279
Simone CamellitiDipartimento Di Scienze Biomediche Per La Salute, Università Degli Studi Di Milano, via Mangiagalli 31, 20133, Milano, Italy.ORCID http://orcid.org/0000-0001-5072-2798
Andrea BalsariDipartimento Di Scienze Biomediche Per La Salute, Università Degli Studi Di Milano, via Mangiagalli 31, 20133, Milano, Italy.ORCID http://orcid.org/0000-0002-3250-2668
Elda TagliabueMolecular Targeting Unit, Department of Research, Fondazione IRCCS, Istituto Nazionale Dei Tumori, via Amadeo 42, 20133, Milano, Italy.ORCID http://orcid.org/0000-0001-9877-2903
Lucia SfondriniDipartimento Di Scienze Biomediche Per La Salute, Università Degli Studi Di Milano, via Mangiagalli 31, 20133, Milano, Italy. lucia.sfondrini@unimi.it.ORCID http://orcid.org/0000-0003-0350-5402
University of Milan · ITFondazione IRCCS Istituto Nazionale dei Tumori · IT

Funding

Fondazione Italiana per la Ricerca sul Cancro 20554
6 · The paper itself

Abstract

Like other body districts, lungs present a complex bacteria community. An emerging function of lung microbiota is to promote and maintain a state of immune tolerance, to prevent uncontrolled and not desirable inflammatory response caused by inhalation of harmless environmental stimuli. This effect is mediated by a continuous dialog between commensal bacteria and immune cells resident in lungs, which express a repertoire of sensors able to detect microorganisms. The same receptors are also involved in the recognition of pathogens and in mounting a proper immune response. Due to its important role in preserving lung homeostasis, the lung microbiota can be also considered a mirror of lung health status. Indeed, several studies indicate that lung bacterial composition drastically changes during the occurrence of pulmonary pathologies, such as lung cancer, and the available data suggest that the modifications of lung microbiota can be part of the etiology of tumors in lungs and can influence their progression and response to therapy. These results provide the scientific rationale to analyze lung microbiota composition as biomarker for lung cancer and to consider lung microbiota a new potential target for therapeutic intervention to reprogram the antitumor immune microenvironment. In the present review, we discussed about the role of lung microbiota in lung physiology and summarized the most relevant data about the relationship between lung microbiota and cancer.

Indexed as

AnimalsHomeostasisHost-Pathogen InteractionsHumansImmune ToleranceInflammationLungMicrobiotaNeoplasmsSymbiosisTumor MicroenvironmentCommensal microorganismsImmune systemImmunological toleranceRespiratory tractTumor

Identifiers

PMID31974656
PMCPMC7326824
OpenAlexW3002288231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.